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Abstract
Background: In 2017 the Nigerian Ministry of Health notified the World Health Organization (WHO) of an outbreak
of hepatitis E located in the north-east region of the country with 146 cases with 2 deaths. The analysis of the
hepatitis E virus (HEV) genotypes responsible for the outbreak revealed the predominance of HEV genotypes 1
(HEV-1) and 2 (HEV-2). Molecular data of HEV-2 genomes are limited; therefore we characterized a HEV-2 strain of
the outbreak in more detail.
Finding: The full-length genome sequence of an HEV-2 strain (NG/17–0500) from the outbreak was amplified using
newly designed consensus primers. Comparison with other HEV complete genome sequences, including the only
HEV-2 strain (Mex-14) with available complete genome sequences and the availability of data of partial HEV-2
sequences from Sub-Saharan Africa, suggests that NG/17–0500 belongs to HEV subtype 2b (HEV-2b).
Conclusions: We identified a novel HEV-2b strain from Sub-Saharan Africa, which is the second complete HEV-2
sequence to date, whose natural history and epidemiology merit further investigation.
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Main text
Hepatitis E virus (HEV) is the prototype of the family
Hepeviridae and a common causative agent of acute
viral hepatitis. HEV is a small, (non)enveloped spherical
particle of about 34 nm in diameter harboring a single
stranded, positive sense RNA genome of approximately
7.5 kb [1]. Eight HEV genotypes are recognized within
the species Orthohepevirus A based on the pairwise dis-
tances of entire viral genomes (HEV-1 to HEV-8). The
different HEV genotypes have various reservoirs, distinct
distribution, and transmission patterns. Four major HEV
genotypes (HEV-1 to HEV-4) are well recognized as hu-
man pathogens while HEV-5 and HEV-6 have been de-
tected only in wild boars so far. HEV-7 from dromedary
camels has been reported to infect humans and cause
chronic hepatitis E. HEV-8 is identified in Bactrian
camels with an unknown zoonotic potential [2–4].
HEV-1 and HEV-2 are transmitted through the water-
borne/fecal-oral route and responsible for large HEV
outbreaks and epidemics in endemic areas like the In-
dian subcontinent and Africa, whereas HEV-3 and
HEV-4 are linked to zoonotic transmission causing spor-
adic infections mainly in industrialized countries [5].
HEV-2 was firstly identified during a hepatitis E out-
break in Mexico in 1986 while the complete genome se-
quence (HPENSSP, GenBank accession No. M74506)
was subsequently characterized [6]. Recently, additional
HEV-2 full-length genome sequences were obtained
from an individual patient of same Hepatitis E outbreak
in Mexico (Mex-14, KX578717) showing 99.5%
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nucleotide identity to M74506 [7]. However, the se-
quences for M74506 and KX578717 are from the same
isolate. Since M74506 has been referred to as Mexico
[8], Mexico-14 [9], and Telixtac-14 [10], the stool sam-
ple was re-analysed at the Paul Ehrlich Institute (PEI),
Germany, with the isolate designation Mex-14, and the
sequences were submitted to GenBank receiving the
accession number KX578717. Additionally, several stud-
ies have reported that HEV-2 is distributed in Africa.
However, only partial ORF2 gene sequences were ampli-
fied [11–14]. According to the report of Lu et al. and the
International Committee on Taxonomy of Viruses
(ICTV) Hepeviridae Study Group, Mex-14 is the pro-
posed HEV subtype 2a (HEV-2a) reference sequence,
Table 1 Primers used for HEV quantification, genotyping, and complete genome sequencing
Primera Sequence (5′-3′) Locationb Use Reference
HEV-07_f GGTGGTTTCTGGGGTGAC 5261–5278 HEV-1 to HEV-4 quantification [18]
HEV-TM3_f FAM-TGATTCTCAGCCCTTCGC-MGB 5284–5301
HEV-08_r AGGGGTTGGTTGGATGAA 5330–5313




HEV-30_f CCGACAGAATTRATTTCGTCGG 6296–6317 HEV-1 to HEV-4 genotyping in ORF2
HEV-32_f GTCTCRGCCAATGGCGAGCCRRC 6350–6372
HEV-31_r GTYTTRGARTACTGCTGR 6750–6733


























aForward primer designations end with _f; reverse primer designations end with _r
bNumbering is according the HEV prototype strain Burma (GenBank accession No. M73218)
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and HEV subtype 2b (HEV-2b) was assigned to the par-
tial sequences AF173231 and AF173232 from Nigeria
and AY903950 from Chad [15, 16].
In June 2017, the Nigerian Ministry of Health reported
to the World Health Organization (WHO) an HEV out-
break in north-east Nigeria, with 146 laboratory con-
firmed cases and two outbreak-associated cases of death
in pregnant [17]. In order to identify the corresponding
viral pathogens of this hepatitis E outbreak, we deter-
mined HEV genotypes from outbreak samples. The geno-
typing results showed mainly HEV-1 and HEV-2 strains
being predominant within the outbreak, the genotype dis-
tribution of isolates from this outbreak as determined by
the Nigerian center of disease control (NCDC) and Robert
Koch Institute (RKI) was 40% HEV-1 and 60% HEV-2.
However, a number of HEV-positive outbreak samples
could not genotyped. Since full-length genome sequences
of HEV-2 strains are rare, we here report the full-length
genome sequence of the HEV-2 strain (NG/17–0500)
from an isolate of the Nigerian outbreak. The virus was
detected from an individual from Borno state, Nigeria,
and initially tested serologically positive for HEV using
Wantai HEV-IgM Rapid Test and Wantai HEV-IgM
ELISA (Sanbio, Uden, Netherland).
Viral RNA from an anonymized serum sample (NG/
17–0500) was extracted using High Pure Viral Nucleic
Acid Kit (Roche, Mannheim, Germany) following cDNA
synthesis using SuperScript™ III First-Strand Synthesis
System (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s instructions. Molecular approaches
with sensitive real-time PCR and consensus nested PCR
assays were conducted as described recently [18]. To
amplify the entire genome sequence of NG/17–0500
and to verify the geno/subtyping results, universal
primers were designed based on 38 complete HEV-1
and HEV-2 sequences from the GenBank database.
Using genome walking method, gene-specific primers
were designed to amplify the gaps. Primers and probe
used are listed in Table 1. The complete viral genome of
NG/17–0500 was amplified using KAPA HiFi HotStart
Fig. 1 Phylogenetic relationships of NG/17–0500 within the species Orthohepevirus A. HEV-2 strains are designated with geno/subtype, accession
number, country, and collection year. NG/17–0500 of this study is shown in red. Phylogenetic analyses were performed with MEGA software version
7.0.26. Maximum likelihood trees based on General Time Reversible model with Gamma distributed with Invariant sites was inferred. The values at
nodes indicate the bootstrap values (using 1000 replications). Values below 70% are hidden for clarity of presentation. Reference sequences for HEV
genotypes were as proposed from the ICTV Hepeviridae Study Group. Nucleotide (nt) and amino acid (aa) sequences were aligned using MAFFT
software version 7.222. a Phylogenetic relationships based on complete genome sequences of representative HEV reference strains. HEV-2 strains are
highlighted with red branches. b Phylogenetic relationships based on 641 nt of ORF 2 corresponding to nt positions 6453 to 7093 (numbered
according to the HEV prototype strain from Burma GenBank accession No. M73218). HEV-2b strains are highlighted with red branches
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ReadyMix PCR kit (Roche, Mannheim, Germany). 5′
and 3′ sequences were determined using 5′ and 3′
rapid amplification of cDNA ends (Roche, Mannheim,
Germany). Sense and antisense strands of PCR ampli-
cons were sequenced with BigDye Terminator version
3.1 cycle sequencing kit (Thermo Fisher Scientific,
USA). Whole genome sequence was assembled and ana-
lyzed using Geneious software version 10.0.5. (Biomat-
ters Limited, Auckland, New Zealand) [19].
Real-time PCR assay targeting the HEV ORF2 and
ORF3 overlapping region (ORF2/3) demonstrated
viremic HEV infection with a viral load of 1.2 × 10E +
7 IU/mL. Sequence analysis of partial ORF1 and ORF2
genes indicated that NG/17–0500 preliminary belongs
to HEV-2. After de novo assembly of the amplicons,
the NG/17–0500 full-length sequence showed 7198 nu-
cleotides, excluding the 3′-poly (A) tail, with a G + C
content of 57.5% harboring the typical 3 HEV ORFs.
Phylogenetic analysis of the complete genome sequence
revealed that NG/17–0500 grouped with HEV-2
Mex-14 strain (Fig. 1a), and this was all true for phylo-
genetic analysis of individual ORFs (data not shown).
These relationships were also observed for sequence
identities between NG/17–500 and other HEV
complete genome or nucleotide or amino acid sequence
identities of individual ORFs (Table 2).
Due to inadequate sanitation and lack of clean drink-
ing water, hepatitis E is a severe public health issue in
several regions of Africa [20]. Partial HEV-2 sequences
have been reported from Sub-Sahara African countries
mainly during HEV outbreaks including Namibia in
1995 [12], Sudan in 2004 [13], and the Central African
Republic in 2002 [14]. In addition, a single study re-
ported of the analysis of HEV isolates from ten sporadic
cases in Port-Harcourt city, southern Nigeria in 1997.
Phylogenetic analysis of partial ORF2 fragments indi-
cated that the Nigerian isolates from 1997 are most
closely related to the HEV-2a reference Mex-14 strain
and have been proposed as HEV-2b [11, 15, 16]. In this
regard, comparison of NG/17–0500 sequence to the pre-
viously characterized Nigerian HEV-2b isolates displayed
a 91.2% to 92.2% nt identity. Phylogenetic analysis of the
Table 2 Nucleotide and amino acid sequence identities between
NG/17–0500 and reference HEV strains within the family Hepeviridaea
Hepeviridae Degree of identity (%)
Complete genome ORF1 ORF2 ORF3
ntb nt aa nt aa nt aa
HEV-1 75.0 72.3 83.5 81.0 94.8 90.9 87.8
HEV-2 83.5 82.3 92.7 86.8 98.2 94.1 91.1
HEV-3 73.1 71.2 81.5 78.7 91.2 83.9 76.4
HEV-4 73.5 71.1 80.6 80.7 91.1 80.6 78.9
HEV-5 72.6 70.1 80.1 78.6 89.1 75.0 74.1
HEV-6 72.8 70.9 79.4 78.0 88.5 75.5 70.5
HEV-7 72.3 69.8 80.6 78.8 89.8 79.0 79.8
HEV-8 72.2 70.0 79.9 77.9 89.4 78.5 81.6
Avian HEV 46.3 44.9 41.3 46.2 43.3 25.6 21.1
Rat HEV 52.1 50.1 48.0 55.1 54.8 38.1 27.1
Bat HEV 47.2 45.8 41.6 55.1 48.1 30.6 15.9
aThe sequences were aligned using MAFFT software version 7.222. The
evolutionary analyses were conducted using MEGA 7 software version 7.0.26.
The GenBank accession numbers are for HEV-1 (M73218), HEV-2 (KX578717),
HEV-3 (AF082843), HEV-4 (AJ272108), HEV-5 (AB573435), HEV-6 (AB602441),
HEV-7 (KJ496143), HEV-8 (KX387865), Avian HEV (AY535004), Rat HEV
(GU345042), and Bat HEV (JQ001749)
bnt and aa represent nucleotide and amino acid, respectively
Fig. 2 Detection of potential recombination events of NG/17–0500 within HEV-1 to HEV-4. a Identity Plot and b BootScan analyses of full-length
sequences were performed using SimPlot software program version 3.5.1 with an F84 distance model, a sliding window size of 300 base pairs
and a step size of 15 base pairs increment. Positions containing gaps were stripped from the alignment
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availability of data of partial HEV-2 sequences from
Sub-Saharan Africa showed that NG/17–0500 clustered
with proposed HEV-2b sequences, indicating NG/17–
0500 belongs to HEV-2b (Fig. 1b). Comparison of partial
ORF2 sequences of NG/17–0500 to Chad (AY903950)
and Central African Republic (DQ151640) HEV-2b iso-
lates shared 90.3% and 88.4% identity, respectively. No
evidence of recombination in NG/17–500 was detected
by either Identity Plot or Bootscan analysis (Fig. 2). The
complete genome sequence of NG/17–0500 has been
deposited in GenBank under the accession number
MH809516.
In conclusion, to the best of our knowledge the novel
HEV-2b strain NG/17–0500 from Nigerian hepatitis E
outbreak 2017 represents the first complete HEV-2 gen-
omic sequence from Sub-Sahara Africa and the second
complete HEV-2 sequence worldwide, which contributes
to our knowledge of the diversity of HEV-2. Neverthe-
less, the natural history of NG/17–0500 requires further
comprehensive genetic and epidemiological analyses.
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